Eric Weisblum - 19 Dec 2022 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: CEO and President, Director
Signature: /s/ Eric Weisblum
Issuer symbol: SILO
Transactions as of: 19 Dec 2022
Transactions value $: $890
Form type: 4
Filing time: 20 Dec 2022, 18:07:59 UTC
Previous filing: 15 Dec 2022
Next filing: 18 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$536	+200	+0.13%	$2.68	154,724	19 Dec 2022	Direct	F1
transaction	SILO	Common Stock	Purchase	$353	+130	+0.08%	$2.72	154,854	20 Dec 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.713. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.713. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.